Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials (Q33940174)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

5 references

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

0 references

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials (English)

1 reference

Europe PubMed Central

30 July 2017

gram-negative bacterial infection

5 references

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

heterocyclic compound

1 reference

17 September 2019

1 reference

7 November 2019

1 reference

11 September 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Pranita D Tamma

1

1 reference

Europe PubMed Central

30 July 2017

Nirupama Putcha

2

1 reference

Europe PubMed Central

30 July 2017

Yong D Suh

3

1 reference

Europe PubMed Central

30 July 2017

Kyle J Van Arendonk

4

1 reference

Europe PubMed Central

30 July 2017

Michael L Rinke

5

1 reference

Europe PubMed Central

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 June 2011

6 references

Europe PubMed Central

30 July 2017

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

BMC Infectious Diseases

6 references

Europe PubMed Central

30 July 2017

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

11

1 reference

Europe PubMed Central

30 July 2017

181

1 reference

Europe PubMed Central

30 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

5 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

22 June 2019

Europe PubMed Central

17 September 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

11 September 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1471-2334-11-181

0 references

Prolonged β-lactam infusion for Gram-negative Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Outcome reporting among drug trials registered in ClinicalTrials.gov

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

The clinical consequences of antimicrobial resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

5 July 2018

Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Comparison of 2 administration protocols (continuous or discontinuous) of a time-dependent antibiotic, Tazocin

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Treatment of gram-negative bacillary septicemia with cefoperazone.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-181

21 January 2018

A preliminary study of the administration of carbapenem antibiotics in sepsis patients on the basis of the administration time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

29 October 2018

Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141415

29 October 2018

Intermittent and continuous ceftazidime infusion for critically ill trauma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21696619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21696619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21696619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21696619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-11-181

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33940174&oldid=1645027464"